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Abstract
Background. Stress echocardiography (SE) is becoming an increasingly frequently performed diagnostic 
examination in Poland. After the published retrospective PolSTRESS Registry, this prospective study is the first 
one available so far.
Objectives. The aim of the study was to analyze SE tests, taking into account the clinical characteristics 
of the patients, indications, applied protocols, and diagnostic and therapeutic decisions.
Material and methods. Reference cardiological centers in Poland were asked for a 1-month prospective 
analysis of the data obtained. The study included 189 SE examinations. To evaluate coronary artery disease 
(CAD) (178 tests), all 17 centers performed dobutamine SE (DSE) (100%), 3 centers (17%) performed pac-
ing, while cycle ergometer and treadmill SE were performed by 1 (5%) and 2 (11%) centers, respectively. 
In patients with valvular heart disease (VHD) (11 tests), 3 centers (16%) performed SE to evaluate low-flow/
low-gradient aortic stenosis (AS), 4 (22%) in asymptomatic AS and 1 (5%) to evaluate mitral regurgitation.
Results. For CAD assessment, a positive result was found in 37 (20%) patients, negative in 109 (61%) and 
nondiagnostic in 32 (19%). In the CAD group, coronarography was performed in 41 (23%) people. The analysis 
of the significance of the SE results for decision-making on interventional measures revealed that 30 patients 
(from the total study population of 189) were referred for the intervention.
Conclusions. The most commonly used SE is the DSE. Negative test results allowed in almost half of the pa-
tients to resign from invasive coronarography. Stress echocardiography should be more frequently used 
in patients with VHD in the qualification for invasive treatment.
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Introduction
Stress echocardiography (SE) is a widely known method 
for the diagnosis of coronary artery disease (CAD) and 
valvular heart disease (VHD), among others, which in-
volves the use of various types of functional tests stim-
ulating contractility and/or inducing ischemia together 
with echocardiographic evaluation of contractility and/
or vascular evaluation of valve flows.1 In CAD diagno-
sis, SE, depending on the type of  load, is characterized 
by a high sensitivity and specificity of the test: exercise 
SE – 80–85% and 80–88% respectively, dobutamine SE 
(DSE) – 79–83% and 82–86%, SE with vasodilatatory agent 
– 72–79% and 92–95%.2 Stress echocardiography is recom-
mended as an initial test to diagnose stable CAD in pa-
tients with a pre-test probability of 66–85% (intermediate) 
or a left ventricular ejection fraction (LVEF) below 50% 
in patients without typical symptomatology. In addition, 
it is performed in patients with abnormalities in resting 
electrocardiograpgy (ECG), which prevent accurate inter-
pretation of ECG changes during loading, in symptomatic 
patients after prior revascularization and in order to assess 
the functional severity of indirect lesions found in coron-
arography.2 In the context of valvular heart defects, SE 
is used in the functional evaluation of a defect, among oth-
ers, in patients with low flow-low gradient aortic stenosis 
(LF-LG AS) (classical and paradoxical). The main features 
of the study were asymptomatic severe aortic stenosis (AS), 
secondary mitral regurgitation (MR), severe asymptomatic 
organic mitral valve regurgitation, and significant asymp-
tomatic mitral stenosis (MVA) <1.5 cm2.3–5
Aim
The aim of the study covered a detailed analysis of SE 
tests performed in Poland, including the clinical char-
acteristics of patients, indications for stress diagnostics 
and applied protocols. Eventually it describes the obtained 
results in terms of further therapeutic decisions based 
on a prospective registry covering a complete 2-month 
study.
Material and methods
Based on the analysis of the annual retrospective Pol-
ish Stress Echocardiography Registry (Pol-STRESS Reg-
istry),6 large medical institutions including cardiology 
centers and the majority of universities in Poland were 
asked to prepare a prospective analysis of data obtained 
at further diagnosis stages. The tests were performed for 
1 month in 2017 by cardiologists or internal medicine prac-
titioners trained in the field of SE. Requirements related 
to equipment standards and operator’s experience have 
been specified by the Echocardiography Working Group 
of the Polish Cardiac Society and the appropriate national 
certification documents.
For a positive SE result in the assessment of myocardial 
ischemia, the authors agreed on the worsening of contrac-
tility in at least 2 segments (in 3 segments for high risk 
stratification) of the echocardiographic left ventricular 
model and for the determination of myocardial viability 
– a typical 2-phase response (improvement of contractility 
at dobutamine dose up to 20 μg/kg/min and its deteriora-
tion at 40 μg/kg/min). In asymptomatic severe AS, patients 
qualified for the study were previously diagnosed with 
aortic valve area (AVA) <1 cm2 (aortic valve area index 
(AVAi) < 0.6 cm2/m2) and mean transvalvular gradient 
(Pmean) >40 mm Hg at rest. Poor prognosis featured: AS 
symptoms, decrease in blood pressure, increase in Pmean 
by at  least 20 mm Hg, risk of pulmonary hypertension 
with systolic pulmonary artery pressure (SPAP) >60 mm 
Hg, and decrease of LVEF. In LF-LG AS (patients with 
LVEF < 40%, AVA < 1 cm2 and Pmean < 40 mm Hg at rest) 
the test indicated severe AS when LVEF or stroke volume 
(SV) improved by more than 20%, Pmean elevated >40 mm 
Hg and AVA remained <1.0 cm2. The lack of LVEF reserve 
(stress ejection fraction–rest ejection fraction) was an in-
dication of a poor prognosis. In MR (ischemic etiology), 
the aim was to assess the EF reserve and the dynamic ef-
fective regurgitant orifice (ERO) component with an in-
crease of over 13 mm2. Statistical descriptive data included 
in the study is presented in numerical and percentage form.
Results
As many as 17 teaching hospitals and large regional cen-
ters in Poland were involved in the study. A total of 189 
SE tests were performed, including 178 diagnosing CAD 
and 11 for VHD assessment (asymptomatic AS, low-flow/
low-gradient AS, MR). Diagnostic tests for CAD were per-
formed in all centers (100%) and examinations to evaluate 
VHD varied from 1 center (5%) for mitral valve disease, 
to  3  centers (17%) for both asymptomatic AS and LF-
LG AS. To evaluate CAD, the protocols used included: 
DSE (all centers, 100%), cycling ergometry (1 center, 5%), 
treadmill (2 centers, 11%), and pacing using atrial mode 
(3 centers, 17%). In order to evaluate VHD, stress methods 
were applied in sequence: 1) in MR – DSE (1 center, 5%); 2) 
in LF-LG AS – DSE (2 centers, 11%) and a cycle ergometer 
(1 center, 5%); 3) in patients with asymptomatic AS – DSE 
(3 centers, 17%) or cycle ergometer (1 center, 5%).
The  study population contained 189 people, includ-
ing 87 men (46%) and 102 women (54%). The average age 
of the patients was 66.4 years. According to the medical 
history of the group studied, 63 (33%) people were patients 
with suspected CAD and 115 (60%) were those with pre-
viously diagnosed CAD based on a history of myocardial 
infarction (44 people), coronary angiography, and in some 
patients based on previously performed non-invasive tests. 
Adv Clin Exp Med. 2019;28(11):1555–1560 1557
A significant VHD had been found in the remaining 14 
(7%) people. Eighty-five (45%) individuals were subjected 
to coronary angiography, 58 (30%) of which were treated 
with percutaneous coronary angioplasty (PCI) and 16 (8%) 
with subsequent coronary artery bypass surgery (CABG). 
In 2 patients, coronary angiography was used for evalua-
tion for valvular intervention, and in 11 cases it preceded 
the implantation of an electrotherapy device. Clinically, 
31 (17%) individuals presented symptoms of typical chest 
angina, 89 (47%) of atypical angina and 25 (15%) patients 
reported non-coronary chest pain (Fig. 1).
The analysis of SE studies performed in patients tested 
for CAD (without previous diagnosis of CAD) revealed that 
the majority of patients, 45 (71%), presented intermediate 
pre-test probability (PTP) of the disease before the test, 
estimated in accordance with the 2013 European Soci-
ety of Cardiology (ESC) guidelines.2 Low PTP was found 
in 17 (27%) patients – SE was performed for the verification 
of ailments and possible functional CAD – and high PTP 
was described in 1 individual (2%) – SE was performed 
for risk stratification and possible revascularization. In all 
patients analyzed for CAD, 28 (16%) were assessed for myo-
cardial viability, the remaining 150 (84%) were subjected 
to provoking test of possible ischemia. Within the 11 VHD 
assessment studies, 6 (55%) involved the analysis of as-
ymptomatic severe AS, 4 studies (36%) were performed 
in patients with LF-LG AS and in 1 case (9%) the study 
was related to a diagnosis of MR (Fig. 2). The ECG analysis 
revealed that 166 (88%) patients had regular sinus rhythm 
at baseline, 13 (6.8%) had atrial fibrillation and 10 (5.2%) 
presented pacemaker rhythm. Intraventricular conduction 
disorders, being the main element that hindered the inter-
pretation of regular ergometry on the treadmill or bicycle 
with ECG recording only, included 16 (8.5%) patients with 
LBBB, 2 (1%) with RBBB and 16 (8.5%) cases with non-
specific intraventricular disorders. The LVEF was 55%, 
which included LVEF >50% in 158 subjects (83%), 40–50% 
in 15 (8%) and less than 40% in as many as 16 (9%).
Most of the tests (150, 79%) were carried out in accor-
dance with the recommendations of the Echocardiography 
Section of the Polish Cardiac Society,1 and the remaining 
39 (21%) in accordance with the guidelines of the European 
Society of Cardiology.4 The differences in the 2 protocols 
are not significant and include, in the first case, early onset 
of atropine administration (from a dose of 30 μg/kg/min 
dobutamine vs 40 μg/kg/min), and for the end test crite-
ria, ST-segment elevation >1 mm (vs >2 mm) on an ECG. 
The  vast majority of  tests, 163 (86%), were performed 
by a cardiologist, 20 tests (10.0%) by a doctor specializ-
ing in cardiology (fellow) and 6 tests (4%) by an internal 
medicine doctor. The stress protocol was predominantly 
with the use of dobutamine (162, 86%). The remaining 
tests were performed using a cycle ergometer (12 tests), 
treadmill (5 tests) or using the stimulation of 10 tests. Do-
butamine stress echocardiogram with a full dose of do-
butamine (40 g/kg) was used in 121 people (75% of DSE) 
and 20 g/kg in 41 (25% of DSE) (Fig. 3). Dipyridamole 
or adenosine were not used in the studies. A positive SE 
score for the assessment of myocardial ischemia or VHD 
was obtained in 46 (24%) people, negative in 110 people 
(58%) and non-diagnostic in 33 (18%). For the assessment 
of CAD, a positive result was reported in 37 (20%) patients, 
negative in 109 (61%) and non-diagnostic in 32 (19%). For 
the evaluation of VHD, a positive result was reported in 9 
(82%) patients, while in negative and non-diagnostic in 1 
individual each (9%) (Fig. 4,5). The average stress time was 
14.4 min (21.6 min for DSE and 7.3 min for exercise SE).
The most common reason for terminating the test accord-
ing to the protocol was obtaining a heart rate limit or ap-
plying maximum doses of drugs. This concerned 141 tests. 
The  reasons for the  premature termination of  the  test 
included: achievement of the test objective, that is, echo-
cardiographically positive result – 39 (20%); or observed 
Fig. 1. Initial clinical characteristics of patients
CAD – coronary artery disease; VHD – valvular heart disease.
Fig. 3. SE protocols
DSE – dobutamine stress echocardiography.
Fig. 2. Valvular heart disease in SE examinations
AS – aortic stenosis; LF-LG AS – low-flow low-gradient aortic stenosis.
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adverse reactions – chest pain 9 (5%), excessive increase 
(5,2%) or decrease (6, 3%) of blood pressure or arrhythmia 8 
(4%). Five (2.5%) tests were discontinued due to patient’s in-
tolerance of the stress agent or 3 (1.5%) at his request (Fig. 6).
The most serious complications of SE (myocardial in-
farction and death) were not observed. After evaluating 
the group with CAD and SE performed for the assessment 
of potential ischaemia, 41 (23%) patients were referred 
to coronary angiography; 20 of those had hemodynamical-
ly insignificant lesions, 19 people had critical and in 2 pa-
tients no coronary artery lesions were detected (Fig. 7).
Among 37 patients with positive SE results, 16 patients 
were diagnosed with critical lesions when subjected 
to coronary angiography. In 2 patients, despite the posi-
tive SE result, no angiography was performed. However, 
among 109 people with negative SE results, 2 patients 
were subjected to coronary angiography, which revealed 
in the 1st case insignificant lesions, and in the 2nd criti-
cal lesions qualified for PCI were described. The analysis 
of the significance of the SE results for the decision-making 
on interventional measurements revealed that 30 patients 
(from the total study population of 189) were referred for 
the intervention. That included 19 individuals for percuta-
neous revascularization (44% of all who underwent angiog-
raphy and 95% with significant lesions), 6 (15%) for surgical 
revascularization, 3 for valvular surgery, 1 patient qualified 
for transcutaneous aortic valve implantation (TAVI), and 
1 for hybrid CABG and valve surgery (Fig. 7,8).
Discussion
The study presented shows the results of the first Pol-
ish prospective multicenter registry of echocardiographic 
Fig. 4. Results of all SE examinations obtained
Fig. 6. Adverse effects during SE
Fig. 5. Results obtained taking into account the diagnostic purpose
CAD – coronary artery disease; VHD – valvular heart disease. Fig. 8. Diagram of VHD management on the basis of SE results obtained 
(number of patients)
SE – stress echocardiography; VHD – valvular heart disease; 
CABG – coronary artery bypass graft; TAVI – transcutaneous aortic 
valve implantation.
Fig. 7. Diagram of CAD treatment based on SE results obtained (number 
of patients)
SE – stress echocardiography; CAD – coronary artery disease; VHD 
– valvular heart disease; PCI – percutaneous coronary intervention; CABG 
– coronary artery bypass graft.
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stress tests (PolStress-Echopro). In  conjunction with 
the recently published6 retrospective registry, Pol-STRESS 
is a  large database reflecting the current situation and 
significance of SE in everyday clinical practice in Poland. 
The analysis involved 17 large cardiology centers, in which 
a total of 189 SEs were performed. In order to make the reg-
istry more objective and reliable, and not limiting its inter-
pretation at the same time, many data points (14.5%) were 
rejected in the course of further analysis due to the lack 
of  full access to  necessary documentation. In  Poland, 
the most frequently performed stress test is the electrocar-
diographic exercise test on a treadmill or cycle ergometer, 
which is mainly due to its wide availability, not the diagnos-
tic power. The sensitivity and specificity of this study are 
45% and 85%, respectively, which, in comparison to SE (83% 
and even 95% with vasodilator), significantly influences 
the interpretation of the outcome and subsequently the fate 
of the patient.2 This data in terms of ischemia makes SE 
the dominant and preferred tool in CAD diagnostics.7
An important factor which elucidates accessibility con-
cerns depends on the reimbursements considerations un-
der the healthcare system. Hence, this published registry 
is considered to raise the awareness among the healthcare 
community of the increasing role of echocardiographic 
functional tests, which may encourage them to increase 
the availability of non-invasive diagnostics measures. All 
centers performed SE with the use of dobutamine, and only 
3 were based on the physiological response of the patient 
during exercise, although it is known for its higher sensitiv-
ity in detecting cardiac ischemia in comparison with do-
butamine and dipyridamole.8 Moreover, exercise SE, in ad-
dition to providing additional prognostic data on physical 
performance, can also be used to diagnose patients with 
valve dysfunction or diastolic insufficiency, which can be 
frequently co-responsible for a patient’s symptoms.9,10 Un-
fortunately, the limited availability of supine stress ergom-
eters in Poland and the application of relatively cheap prov-
ocation agents affects the type of protocol used. Among 
all institutions included in the study, only 3 used a previ-
ously implanted pacemaker. The usage of fast pacing allows 
the physician to perform the test as accurately and safely 
as using the previously described modalities, but can in-
fluence the result interpretation in the case of ventricular 
pacing or the occurrence of the Wenckebach point below 
the target pulse rate.1,10 This small number was related 
to the patient profile and the limited group of patients 
with a pacemaker. Furthermore, none of the centers used 
adenosine or dipyridamole. The knowledge of key features 
and contraindications to a particular type of stress has 
significant importance in terms of appropriate method 
selection, making the result even more specific.10
The main reason of implementing SE remained CAD 
and this indication dominated in all centers. Stress echo-
cardiography is recommended in symptomatic patients and 
in moderate PTP to detect myocardial ischemia, as well 
as in those without typical angina and LVEF < 50% or after 
incomplete revascularization.2 This is convergent with our 
results, where most patients presented intermediate PTP. 
Only 1 individual was diagnosed with high PTP, which also 
seems to be reasonable in terms of incident risk and direct 
qualification for invasive measures. However, Papachristidis 
et al.11 proved that SE can also influence this group of pa-
tients. In “only” 41% of those with high PTP was the SE score 
positive; 57% of them were subjected to coronary angiogra-
phy and 24.6% were treated with PCI. Compared to the rou-
tine approach in accordance with ESC recommendations, 
a significant reduction in procedure costs was observed, 
with only a small percentage of serious adverse cardiac 
and cerebrovascular events (Major Adverse Cardiac and 
Cerebrovascular Events – MACCE). In current recommen-
dations, SE also plays a key role in more challenging cases 
of VHD such as: asymptomatic AS, LF-LG AS (both classic 
low-gradient with Pmean < 40 mm Hg and EOA < 1 cm2, and 
– paradoxically – with preserved LVEF and low SV < 35 mL/
m2), or in MR. Unfortunately, the use of advantages of SE 
in VHD is limited to only a few centers, which is signifi-
cantly different from the United Kingdom National Health 
Service Survey data (almost 99% of centers), where, except 
for the VHDs listed in PolStress-Echopro, severe MVA 
(25% of centers) and asymptomatic severe aortic regurgi-
tation (18% of centers) were evaluated.12 New guidelines 
for the treatment of VHDs which appeared recently should 
influence the wider management of SE in the assessment 
of VHD, thus improving further therapeutic decisions and 
patients’ prognosis.13,14 The guidelines contain some mi-
nor modifications related to the outcome of SE performed 
in asymptomatic AS and in primary asymptomatic MR.13 
The class IIb C indication for valvular surgery in asymp-
tomatic AS when the mean gradient increased by >20 mm 
Hg in the SE exercise test, was excluded. Similarly, in pa-
tients with primary asymptomatic MR, exertional increase 
in systolic pressure in the pulmonary artery >60 mm Hg 
is no longer considered an indication for surgery.
The areas of SE applications are not only limited to CAD 
and VHD (including valve prostheses) – SE may and should 
also be performed for other indications such as diastolic 
dysfunction, cardiomyopathy (dilated, hypertrophic), re-
synchronization therapy, pulmonary hypertension, con-
genital heart diseases (coarctation of the aorta, atrial sep-
tal defect, tetralogy of Fallot, single-chamber heart), and 
the athlete’s heart.15
In the study presented, tests used for CAD assessment 
revealed the negative SE result in 61% of patients, which re-
sulted in resignation from invasive testing that could have 
involved the possibility of serious complications. However, 
one of the patients with negative DSE who was referred 
to coronarography had critical coronary lesions.
It should be noted that among the 37 individuals with 
positive DSE, only 16 had hemodynamically significant 
lesions. This might be due to inadequate interpretation 
of the SE outcomes and false-positive results in cases such 
as: poor test conditions, changes in  the basal segment 
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of the inferior wall, the presence of asynchrony of the ven-
tricular septum in a patient with LBBB, in a patient after 
cardiac surgery and in the lesion in the left coronary ar-
tery circumflex branch.10 As many as 19% of tests did not 
have diagnostic power, which corresponds with data from 
the available literature (5–20%).16 The use of contrast agents 
would increase the accuracy of diagnosis, but also raise 
the cost of the study, thus it was not used in any center.17
The PolStress-Echopro registry has once again demon-
strated the great safety of SE, which, considering its high 
sensitivity and specificity, makes it a unique diagnostic tool 
in patients with CAD and VHD. The most frequent stress 
effects resulted in stenocardial pain (subjective, not related 
to CAD severity) and fluctuations in blood pressure, which 
required premature discontinuation of the study. There 
were no serious adverse events such as death or myocardial 
infarction observed. For comparison, those complications 
are described in the UK-NHSS register (1 and 8 centers 
respectively).12 Nevertheless, SE is considered a safe diag-
nostic method, with mortality rate and myocardial infarc-
tion estimated at <0.01% and 0.01–0.1%, respectively.18,19
An undoubted limitation of this study that needs to be 
mentioned is the absolute number of the exams analyzed 
and the time of observation. Both in the retrospective Pol-
STRESS Registry and the currently referenced prospec-
tive PolStress-Echopro, the number of SEs performed for 
the purpose of CAD assessment was predominant. This 
data is consistent and should be interpreted in a coherent 
and comprehensive manner, as well to confirm the conclu-
sions of the work presented below on the necessity of wider 
dissemination of this method in the assessment of VHD. 
However, when analyzing the number of tests and the time 
of observation between both registries, the results obtained 
are proportional to the time of observation.
Conclusions
The most commonly used echocardiographic stress test 
in the diagnosis of coronary heart disease is DSE. Negative 
test results in the CAD diagnoses made it possible to avoid 
invasive coronary angiography in almost half of the pa-
tients. The proven high value and SE safety in assessing 
the significance of selected heart valve defects should lead 
to more frequent use of these methods in the qualification 
of patients for surgical treatment.
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